Boston PartnersBoston Partners

Institutional investor · Portfolio as of Q1 2021

Top Holdings645 positions

Checking export access…
Activity:

JPMORGAN CHASE & CO

8.4M$1.3B1.7%$90.78+45.53%
10 qtrssince 2018-Q4
Decreased
0

JOHNSON & JOHNSON

7.3M$1.2B1.6%$112.13+25.93%
10 qtrssince 2018-Q4
Increased
51

BANK OF AMER CORP

29.8M$1.2B1.5%$20.82+62.90%
10 qtrssince 2018-Q4
Decreased
0

AUTOZONE INC

740,459$1B1.4%$1,002.41+40.09%
9 qtrssince 2019-Q1
Increased
53

TRUIST FINL CORP

17.3M$1B1.4%$38.22+18.06%
6 qtrssince 2019-Q4
Increased
51

CISCO SYS INC

18.7M$969.2M1.3%$38.30+15.31%
10 qtrssince 2018-Q4
Increased
59

DUPONT DE NEMOURS INC

11.2M$862M1.2%——
8 qtrssince 2019-Q2
Increased
51

EATON CORP PLC

6.2M$851.1M1.1%$64.88+95.30%
10 qtrssince 2018-Q4
Increased
51

CONOCOPHILLIPS

15.8M$836.9M1.1%$38.00+14.95%
10 qtrssince 2018-Q4
Decreased
0

FIFTH THIRD BANCORP

21.6M$807.7M1.1%$16.87+81.35%
10 qtrssince 2018-Q4
Increased
52

HUNTINGTON BANCSHARES INC

50.4M$791.9M1.1%$7.52+64.29%
10 qtrssince 2018-Q4
Decreased
0

CITIGROUP INC

10.7M$777.2M1.0%$43.79+38.07%
10 qtrssince 2018-Q4
Increased
52

THE CIGNA GROUP

3.2M$772.3M1.0%$163.00+33.99%
10 qtrssince 2018-Q4
Decreased
0

BERKSHIRE HATHAWAY INC DEL

3M$769.6M1.0%$204.63+24.84%
10 qtrssince 2018-Q4
Decreased
0

ELEVANCE HEALTH INC FORMERLY

2.1M$754.1M1.0%$234.63+41.36%
10 qtrssince 2018-Q4
Decreased
0

NXP SEMICONDUCTORS N V

3.7M$746M1.0%$88.48+106.44%
9 qtrssince 2019-Q1
Increased
52

MEDTRONIC PLC

5.7M$669.5M0.9%$75.10+32.73%
10 qtrssince 2018-Q4
Decreased
0
QRVOQRVODelisted

QORVO INC

3.6M$666.7M0.9%——
10 qtrssince 2018-Q4
Decreased
0

ALPHABET INC

317,577$655.9M0.9%$58.58+74.37%
10 qtrssince 2018-Q4
Decreased
0

MARATHON PETE CORP

12.2M$651M0.9%$47.55-1.31%
10 qtrssince 2018-Q4
Increased
52
$74.6B
AUM
645
Positions
Q1 2021
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+2%Q4'19$75.6B-33%Q1'20$50.4B+8%Q2'20$54.4B+1%Q3'20$54.9B+17%Q4'20$64.3B+16%Q1'21$74.6B
Activity profile
$ moved · Q1'21
New20%Increased45%Decreased29%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.6 years
<1Q10%1-4Q16%1-2Y17%2Y+58%

Boston Partners manages $74.6B across 645 positions as of Q1 2021. Top holdings: JPM (1.7%), JNJ (1.6%), BAC (1.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q1 2021 Summary

Active quarter - 84 new positions, 57 exits, 250 increased. Top move: CSCO (INCREASED, conviction 59). Portfolio: $74.6B across 645 positions.

Top holdings by portfolio weight

Total AUM$75B
JPM1.72%
JNJ1.62%
BAC1.54%
AZO1.40%
TFC1.35%
CSCO1.30%
DD1.16%
ETN1.14%
COP1.12%
FITB1.08%
Other1.06%

Portfolio allocation by GICS sector

Sectors11
Financial Services20.82%
Industrials15.58%
Healthcare13.71%
Technology12.41%
Consumer Cyclical11.83%
Unknown5.65%
Basic Materials5.03%
Energy5.03%
Communication Services3.60%
Real Estate2.22%
Other4.13%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Industrials, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L66
Conviction38
Concentration23
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BKVBKVBKV CORP
Q4 2024 → Q2 2026+2.5M shares+$69.4M
7Q
INVAINVAINNOVIVA INC
Q4 2024 → Q2 2026+1.6M shares+$37.2M
7Q
KROKROKRONOS WORLDWIDE INC
Q4 2024 → Q2 2026+2.3M shares+$9.7M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used